The feasibility of classical cyclophophamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: A study of consistency in relative dose intensity (RDI) and cumulative doses across institutions
